Ads
related to: johnson and johnson stock price- Latest news
The latest financial news.
Learn more from J&J.
- Quarterly results
Get information about
J&J's quarterly results.
- Latest news
Search results
J&J-backed Rapport Therapeutics seeks about $637 million valuation in US IPO
AOL· 13 hours agoThe U.S. IPO market is staging a strong comeback after two dismal years, thanks to a rally in the stock market and growing optimism of a possible interest ...
Target's poor Pride Month decision proves companies can’t have it both ways
The Advocate· 19 hours agoAt agencies, I also worked with brands including Johnson & Johnson, Disney, Dunkin’ Donuts, and...
Earnings call: Johnson Matthey reports mixed financial results By Investing.com
Investing.com· 6 days agoJohnson Matthey (LON:JMAT), a global leader in sustainable technologies, hosted an earnings call to...
Johnson & Johnson (JNJ) Rises As Market Takes a Dip: Key Facts
Zacks· 5 days agoJohnson & Johnson (JNJ Quick QuoteJNJ - Free Report) closed the latest trading day at $145.28, indicating a +0.58% change from the previous session's end ...
7 Overlooked Stocks That Belong in Every Portfolio
InvestorPlace· 20 hours agoOverlooked stocks are not necessarily underperforming the market. In some cases, these stocks simply are slow and steady at a time when investors want to...
Johnson Financial Group Inc. Increases Stock Holdings in The Goldman Sachs Group, Inc. (NYSE:GS)
ETF DAILY NEWS· 7 days ago(NYSE:GS – Free Report) by 140.3% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 286 shares of ...
Is Now The Time To Buy Johnson & Johnson
Stocks Register· 7 days agoJohnson & Johnson (NYSE:JNJ) price closed lower on Friday, May 24, dropping -1.82% below its previous close. A look at the daily < ...
Johnson Financial Group Inc. Makes New $28,000 Investment in Celanese Co. (NYSE:CE)
ETF DAILY NEWS· 6 days agoJohnson Financial Group Inc. acquired a new stake in shares of Celanese Co. (NYSE:CE – Free Report)...
HealthTech Heroes: 3 Medical Technology Stocks to Buy Before They Boom
InvestorPlace via Yahoo Finance· 6 days agoWhile the biotechnology sector may receive most of the attention under the broad healthcare...
Johnson & Johnson's Drug Seltorexant Aces Late-Stage Depression Trial
Benzinga via AOL· 5 days agoWednesday, Johnson & Johnson (NYSE:JNJ) announced topline results from Phase 3 MDD3001 clinical...
